FDA recommends lower dose of zolpidem for patient safety

In a drug safety communication, FDA has recommended that the bedtime dose of zolpidem, for the treatment of insomnia, be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.
Source: Modern Medicine - Category: Journals (General) Source Type: news